New strategies for advanced neuroendocrine tumors in the era of targeted therapy
about
The pivotal role of mammalian target of rapamycin inhibition in the treatment of patients with neuroendocrine tumorsMolecular classification of gastric cancer: Towards a pathway-driven targeted therapyChallenges in the Diagnosis and Management of Well-Differentiated Neuroendocrine Tumors of the Lung (Typical and Atypical Carcinoid): Current Status and Future ConsiderationsEvaluation of the WHO 2010 grading and AJCC/UICC staging systems in prognostic behavior of intestinal neuroendocrine tumorsMutation-targeted therapy with sunitinib or everolimus in patients with advanced low-grade or intermediate-grade neuroendocrine tumours of the gastrointestinal tract and pancreas with or without cytoreductive surgery: protocol for a phase II clinicaLong-term management of a patient with well-differentiated pulmonary neuroendocrine carcinoma: a case reportTherapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advancesDirect cytosolic delivery of polar cargo to cells by spontaneous membrane-translocating peptides.Identification of immunotherapeutic targets by genomic profiling of rectal NET metastases.Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future.Update on the management of gastroenteropancreatic neuroendocrine tumors with emphasis on the role of imaging.The role of mechanistic target of rapamycin (mTOR) complexes signaling in the immune responses.New horizons for targeted treatment of neuroendocrine tumors.Histological features of mixed neuroendocrine carcinoma and hepatocellular carcinoma in the liver: a case report and literature review.p53 suppresses carcinoma progression by inhibiting mTOR pathway activation.Surgery for giant primary neuroendocrine carcinoma of the liver.Transcriptional alterations in hereditary and sporadic nonfunctioning pancreatic neuroendocrine tumors according to genotype.Neuroendocrine neoplasms of the pancreas at dynamic enhanced CT: comparison between grade 3 neuroendocrine carcinoma and grade 1/2 neuroendocrine tumour.Rapid improvement of glucagonoma-related necrolytic migratory erythema with octreotide.Grading of pancreatic neuroendocrine neoplasms using pharmacokinetic parameters derived from dynamic contrast-enhanced MRI.
P2860
Q26740374-D7364444-7746-4570-830E-0726C0B17542Q26798420-B0F31EF6-9644-4297-85B7-8EF7DE57391BQ28084155-4C523D7B-0CF9-432B-AA89-268C338AF28CQ34688938-565824FE-9B25-43AF-8F15-79B9C2B06AD5Q35640506-115B2C9C-4060-4EC2-BC3F-541610BADC58Q36797100-C8BB3E81-DE69-4614-8D67-43996898EAACQ37125550-EFBAE89D-9BBF-4AAB-8758-4C1D6A9F82C7Q37226280-95C42361-513A-44F0-B384-A3F05CA4F76DQ37477282-B1E3C44B-CA77-4742-BFEA-C84A4F5594BFQ37631597-1941EBB4-F722-4ABD-AA2E-0B9219408DA0Q37673407-9B408A51-E777-43F8-8EFF-A2A7B82CB0D7Q38115702-8CE16769-FF19-4B50-825E-60BC9C3EEDEBQ38750685-2067AF23-E3EB-44A6-A1A2-311820EDD312Q38888050-D05DA65A-0339-4570-9CA1-9B2CCC9F6A0CQ39029976-05DB2C21-A201-4EE6-BE78-DFD81FD3ACA5Q44636100-79E9EBBF-A418-4EB0-A820-832232E7AF6BQ47391475-F735A76D-57A0-44B9-8AFD-52A05FFBAF09Q53037246-AE17C648-EF02-475B-8463-981CB585653DQ53422328-2634A020-8B56-4E28-AA07-6E3656059BE0Q55255348-E2FA728B-3268-43CE-B299-D6066DF86365
P2860
New strategies for advanced neuroendocrine tumors in the era of targeted therapy
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
New strategies for advanced neuroendocrine tumors in the era of targeted therapy
@ast
New strategies for advanced neuroendocrine tumors in the era of targeted therapy
@en
New strategies for advanced neuroendocrine tumors in the era of targeted therapy
@nl
type
label
New strategies for advanced neuroendocrine tumors in the era of targeted therapy
@ast
New strategies for advanced neuroendocrine tumors in the era of targeted therapy
@en
New strategies for advanced neuroendocrine tumors in the era of targeted therapy
@nl
prefLabel
New strategies for advanced neuroendocrine tumors in the era of targeted therapy
@ast
New strategies for advanced neuroendocrine tumors in the era of targeted therapy
@en
New strategies for advanced neuroendocrine tumors in the era of targeted therapy
@nl
P2093
P3181
P1476
New strategies for advanced neuroendocrine tumors in the era of targeted therapy
@en
P2093
P304
P3181
P356
10.1158/1078-0432.CCR-11-2105
P407
P577
2012-04-01T00:00:00Z